VSee Health, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VSee Health, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $949.14K, a 947.23% increase year-over-year.
- VSee Health, Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $90.63K.
- VSee Health, Inc. stock issued during period, value, new issues for the quarter ending 2023-03-31 was $214.20K.
- VSee Health, Inc. stock issued during period, value, new issues for the quarter ending 2021-06-30 was $25.00K.
- VSee Health, Inc. stock issued during period, value, new issues for fiscal 2025 was $13.54M.
- VSee Health, Inc. stock issued during period, value, new issues for fiscal 2023 was $214.20K, a 24.69% decline from fiscal 2022.
- VSee Health, Inc. stock issued during period, value, new issues for fiscal 2022 was $284.42K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $949.14K 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $13.54M 10-K · filed 2026-03-31 | |
| 2025-03-31 | $90.63K 10-Q · filed 2026-05-15 | |
| 2023-12-31 | $214.20K 10-K · filed 2024-04-12 | |
| 2023-03-31 | $214.20K 10-Q · filed 2024-05-15 | |
| 2022-12-31 | $284.42K 10-K · filed 2023-04-12 | |
| 2021-06-30 | $25.00K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |